Triclocarban 1.5% Category I Antimicrobial Status Sought By P&G
This article was originally published in The Rose Sheet
Executive Summary
FDA should include triclocarban at levels of up to 1.5% as a Category I ingredient in its OTC topical antimicrobial products final monograph, Procter & Gamble states in Aug. 19 comments to the agency
You may also be interested in...
Antiseptic Log Reduction Criteria Should Stand, NDAC Recommends
Current log reduction criteria to measure the efficacy of topical antiseptic products should not be reduced due to a lack of "compelling" data to support revising the standards, FDA's Nonprescription Drugs Advisory Committee concluded during a March 23 meeting in Gaithersburg, Md
Antiseptic Log Reduction Criteria Should Stand, NDAC Recommends
Current log reduction criteria to measure the efficacy of topical antiseptic products should not be reduced due to a lack of "compelling" data to support revising the standards, FDA's Nonprescription Drugs Advisory Committee concluded during a March 23 meeting in Gaithersburg, Md
CTFA Antiseptic Log Reduction Criteria Will Be Topic Of NDAC Meeting
A request from the Cosmetic, Toiletry and Fragrance Association to FDA's Division of Over-The-Counter Drug Products to consider reducing the current log reduction criteria used to measure the efficacy of topical antiseptic products will be discussed at a March 23 meeting of the Nonprescription Drugs Advisory Committee in Gaithersburg, Md